The trades
Rtw Investments, LP (ten-percent owner) bought 1.2 million shares at $5.00 on Nov 9, 2026, worth $6.0M. (SEC EDGAR, Form 4, Nov 12, 2026)
Fain Eric S (director) bought 20,000 shares at $5.00 on Nov 9, 2026, worth $100K. (SEC EDGAR, Form 4, Nov 9, 2026)
Pacitti David (director) bought 20,000 shares at $5.00 on Nov 9, 2026, worth $100K. (SEC EDGAR, Form 4, Nov 9, 2026)
Hochman David P (See Remarks, director) bought 5,000 shares at $5.00 on Nov 9, 2026, worth $25K. (SEC EDGAR, Form 4, Nov 9, 2026)
Taylor Andrew Lawrence (CFO) bought 1,000 shares at $5.00 on Nov 9, 2026, worth $5.0K. (SEC EDGAR, Form 4, Nov 9, 2026)
The past year
Open-market purchases in the SEC insider data sets come to $280K over the twelve months through Sep 30, 2026, from 4 buyers. (SEC insider transactions data sets (open-market trades), Sep 30, 2026)
Open-market sales over the same months come to $258K, from 2 sellers. (SEC insider transactions data sets (open-market trades), Sep 30, 2026)
The stock
The Nasdaq screener puts its market value at $484.0M. (Nasdaq stock screener, Nov 13, 2026)
Orchestra BioMed Holdings Inc. has about 5.3 months of cash at its recent burn
The 10-Q that Orchestra BioMed Holdings Inc. (OBIO) filed on Nov 10, 2026 covers the quarter ended Sep 30, 2026. (SEC XBRL company facts, 10-Q, Nov 10, 2026)
Follow it up
The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/OBIO)
The filing on SEC EDGAR. (sec.gov)
Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.